66 related articles for article (PubMed ID: 35524422)
1. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
2. Circ-LDLRAD3/miR-655-3p/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma.
Zhang B; Peng Y; Zhou L
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):150-155. PubMed ID: 38430029
[TBL] [Abstract][Full Text] [Related]
3. MiR-1a-3p Inhibits Apoptosis in Fluoride-exposed LS8 Cells by Targeting Map3k1.
Chen T; Gu Y; Bai GH; Liu X; Chen B; Fan Q; Liu JG; Tian Y
Biol Trace Elem Res; 2024 Jun; 202(6):2720-2729. PubMed ID: 37782397
[TBL] [Abstract][Full Text] [Related]
4. Hyperbranched polyamidoamine-RGD peptide/si-
Dong S; Xia Q; Pan J; Du XL; Wu YJ; Xie XJ
Nanomedicine (Lond); 2023 Nov; 18(27):2039-2059. PubMed ID: 38131284
[No Abstract] [Full Text] [Related]
5. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Xiong Y; Kotian S; Zeiger MA; Zhang L; Kebebew E
PLoS One; 2015; 10(8):e0130496. PubMed ID: 26244545
[TBL] [Abstract][Full Text] [Related]
6. miRNA-363-3p Hinders Proliferation, Migration, Invasion and Autophagy of Thyroid Cancer Cells by Controlling SYT1 Transcription to affect NF-κB.
Zhang J; Ren G; Huang T; Sang Y; Zhong Y; Yi Y
Endocr Metab Immune Disord Drug Targets; 2024; 24(1):153-162. PubMed ID: 37150983
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation and clinical significance of miR-7-2-3p in papillary thyroid carcinoma with multiple detecting methods.
Wu HY; Wei Y; Pan SL
IET Syst Biol; 2019 Oct; 13(5):225-233. PubMed ID: 31538956
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer.
Qasemi Rad M; Pouresmaeil V; Hosseini Mojahed F; Amirabadi A; Aalami AH
Mol Biol Rep; 2022 Jul; 49(7):6975-6985. PubMed ID: 35511316
[TBL] [Abstract][Full Text] [Related]
9. miR-196b inhibits cell migration and invasion through targeting MAP3K1 in hydatidiform mole.
Guo Z; Sui L; Qi J; Sun Q; Xu Y; Zou N; Xie Y; Kong Y
Biomed Pharmacother; 2019 May; 113():108760. PubMed ID: 30889489
[TBL] [Abstract][Full Text] [Related]
10. Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP.
Chen Y; Zhang S; Zhao R; Zhao Q; Zhang T
Oncol Res; 2017 Sep; 25(8):1215-1222. PubMed ID: 27938505
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin Inhibits the Progression of Obesity-Associated Papillary Thyroid Carcinoma Through Autophagy.
Li C; Zhang J; Dionigi G; Liang N; Guan H; Sun H
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38492235
[TBL] [Abstract][Full Text] [Related]
12. MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells.
Aakko S; Straume AH; Birkeland EE; Chen P; Qiao X; 'Lønning PE; Kallio MJ
Transl Oncol; 2019 Jan; 12(1):170-179. PubMed ID: 30359947
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑203a‑3p improves bleomycin and pingyangmycin sensitivity by inactivating the PI3K/AKT pathway in hemangioma.
Zhuo L; Hu Z; Chang J; Guo Q; Guo J
Exp Ther Med; 2024 Feb; 27(2):80. PubMed ID: 38274341
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.
Dai L; Zhang W; Wu X; Zhou S
J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
[TBL] [Abstract][Full Text] [Related]
15. MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.
Stojanović S; Dobrijević Z; Šelemetjev S; Đorić I; Janković Miljuš J; Živaljević V; Išić Denčić T
Endocrine; 2023 Jan; 79(1):98-112. PubMed ID: 36103016
[TBL] [Abstract][Full Text] [Related]
16. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
17. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
18. miR-203a-A multifaceted regulator modulating cancer hallmarks and therapy response.
Biswal P; Lalruatfela A; Behera SK; Biswal S; Mallick B
IUBMB Life; 2024 Mar; 76(3):108-124. PubMed ID: 37792370
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
